Prostate Cancer Clinical Trials in Anaheim, CA

Prostate Cancer Clinical Trials in Anaheim, CA

View the best 10 prostate cancer medical studies in Anaheim, California. Access promising new therapies by applying to a Anaheim-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Anaheim, California

Here are the top 10 medical studies for prostate cancer in Anaheim, California

Image of University of Alabama at Birmingham in Birmingham, United States.


Androgen Deprivation Therapy

Recruiting1 awardPhase 3
This trial is testing whether abemaciclib, when added to abiraterone plus prednisone, can help to treat prostate cancer by prolonging the time before the cancer gets worse.
Image of Duly Health and Care in Lisle, United States.

NanoKnife System

Irreversible Electroporation

Recruiting1 award12 criteria
This trial will study whether the NanoKnife System is a safe and effective treatment option for intermediate-risk prostate cancer patients.
Image of Research Site in Lakewood, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Image of Arizona Institute of Urology, PPLC in Tucson, United States.

177Lu-PSMA-I&T +1 More

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial is comparing the safety and efficacy of 177Lu-PSMA-I&T (a treatment for prostate cancer) to hormone therapy.
Image of Mid Florida Hematology and Oncology Center in Orange City, United States.

MGC018 +1 More

Antibody-drug conjugate

Recruiting1 awardPhase 2
This trial is testing an experimental drug (MGC018) for mCRPC patients who have had prior ARAT and taxane-containing treatment. 150 participants will be randomized 1:1:1 in Phase 2, and 270 will be randomized 1:1 in Phase 3.
Image of Arkansas Urology in Little Rock, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new combination of drugs to treat men with aggressive prostate cancer that has spread and who have a specific genetic mutation.
Image of Sarah Cannon Research Institute MCC in Asheville, United States.


Androgen Receptor Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, ZEN003694, to see if it is more effective than the current standard of care, enzalutamide, in patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed on prior abiraterone. Patients will be randomized to receive either ZEN003694 in combination with enzalutamide or enzalutamide monotherapy. The primary endpoint is radiographic progression-free survival (rPFS) by PCWG3 criteria.
Image of Yale Cancer Center in New Haven, United States.

Radical Prostatectomy +1 More


Recruiting1 award6 criteria
This trial will compare a new, less invasive prostate cancer treatment to the standard surgery. Researchers will track patients for 10 years to see if the new treatment is just as effective and less risky.
Image of Carolina BioOncology Institute in Huntersville, United States.



Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, NUV-868, for safety and efficacy in patients with advanced solid tumors. The drug will be taken orally, either as a monotherapy or in combination with other drugs olaparib or enzalutamide, in 28-day cycles. The trial will continue until the disease progresses, there are unacceptable side effects, the patient withdraws consent, or the trial is terminated.
Image of Research Site in Tucson, United States.

AZD5305 +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial tests a new drug for advanced prostate cancer to see if it can slow down the spread of the disease.

Popular filter options for prostate-cancer anaheim trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Prostate-cancer Anaheim Trials

See another 82 medical studies focused on prostate-cancer anaheim.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.